Shenzhen Cost Of Revenue vs Net Income From Continuing Ops Analysis

300942 Stock

8.48 0.50 5.57%

Shenzhen Bioeasy financial indicator trend analysis is much more than just breaking down Shenzhen Bioeasy Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shenzhen Bioeasy Bio is a good investment. Please check the relationship between Shenzhen Bioeasy Cost Of Revenue and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shenzhen Bioeasy Bio Cost Of Revenue account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Shenzhen Bioeasy's Cost Of Revenue and Net Income From Continuing Ops is -0.14. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Shenzhen Bioeasy Biotechnology, assuming nothing else is changed. The correlation between historical values of Shenzhen Bioeasy's Cost Of Revenue and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Shenzhen Bioeasy Biotechnology are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Cost Of Revenue i.e., Shenzhen Bioeasy's Cost Of Revenue and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Shenzhen Bioeasy Bio income statement and represents the costs associated with goods and services Shenzhen Bioeasy provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income From Continuing Ops

Most indicators from Shenzhen Bioeasy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shenzhen Bioeasy Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 14 M, whereas Selling General Administrative is forecasted to decline to about 76.7 M.

	2021	2022	2023	2024 (projected)
Interest Expense	5.3M	4.1M	10.6M	11.2M
Tax Provision	31.6M	12.2M	7.2M	14.0M

Interest Expense Tax Provision

Shenzhen Bioeasy fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Capital Surpluse	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Stockholder Equity	Net Invested Capital	Capital Stock
Total Assets		0.97	0.99	0.86	0.83	0.91	0.99	0.93	0.95	0.79	0.82	0.53	0.82	0.96	-0.82	0.9	0.94	0.93	-0.9	0.94	0.91	0.46	0.66	-0.86	0.93	0.85
Total Current Liabilities	0.97		0.98	0.92	0.7	0.89	0.94	0.92	0.89	0.79	0.91	0.68	0.75	0.92	-0.78	0.89	0.88	0.91	-0.87	0.92	0.89	0.6	0.55	-0.87	0.89	0.76
Total Stockholder Equity	0.99	0.98		0.93	0.83	0.89	0.98	0.97	0.96	0.75	0.89	0.53	0.76	0.98	-0.86	0.91	0.95	0.91	-0.9	0.89	0.85	0.54	0.57	-0.83	0.87	0.77
Retained Earnings	0.86	0.92	0.93		0.67	0.78	0.85	0.93	0.84	0.65	0.97	0.53	0.55	0.92	-0.79	0.83	0.84	0.79	-0.81	0.74	0.65	0.77	0.33	-0.74	0.71	0.54
Cash	0.83	0.7	0.83	0.67		0.72	0.86	0.88	0.94	0.5	0.58	0.13	0.68	0.89	-0.88	0.75	0.93	0.71	-0.76	0.66	0.62	0.14	0.6	-0.53	0.66	0.68
Other Assets	0.91	0.89	0.89	0.78	0.72		0.85	0.82	0.83	0.87	0.77	0.41	0.92	0.86	-0.72	0.9	0.81	0.98	-0.96	0.93	0.89	0.33	0.81	-0.88	0.93	0.9
Cash And Short Term Investments	0.99	0.94	0.98	0.85	0.86	0.85		0.94	0.96	0.73	0.79	0.48	0.75	0.96	-0.83	0.87	0.96	0.87	-0.85	0.9	0.86	0.48	0.58	-0.81	0.89	0.81
Net Receivables	0.93	0.92	0.97	0.93	0.88	0.82	0.94		0.95	0.69	0.86	0.42	0.69	0.99	-0.92	0.84	0.94	0.84	-0.83	0.79	0.72	0.53	0.51	-0.75	0.78	0.68
Common Stock Shares Outstanding	0.95	0.89	0.96	0.84	0.94	0.83	0.96	0.95		0.6	0.79	0.4	0.73	0.96	-0.86	0.88	1.0	0.83	-0.87	0.8	0.77	0.39	0.58	-0.69	0.79	0.73
Capital Surpluse	0.79	0.79	0.75	0.65	0.5	0.87	0.73	0.69	0.6		0.61	0.41	0.88	0.7	-0.62	0.66	0.57	0.92	-0.73	0.9	0.84	0.29	0.79	-0.94	0.91	0.89
Inventory	0.82	0.91	0.89	0.97	0.58	0.77	0.79	0.86	0.79	0.61		0.64	0.52	0.85	-0.73	0.86	0.79	0.75	-0.83	0.71	0.66	0.77	0.29	-0.69	0.67	0.48
Other Current Assets	0.53	0.68	0.53	0.53	0.13	0.41	0.48	0.42	0.4	0.41	0.64		0.34	0.37	-0.35	0.46	0.41	0.44	-0.41	0.52	0.65	0.46	0.15	-0.49	0.48	0.28
Total Liab	0.82	0.75	0.76	0.55	0.68	0.92	0.75	0.69	0.73	0.88	0.52	0.34		0.72	-0.64	0.7	0.69	0.94	-0.8	0.89	0.89	0.0	0.96	-0.86	0.91	0.95
Total Current Assets	0.96	0.92	0.98	0.92	0.89	0.86	0.96	0.99	0.96	0.7	0.85	0.37	0.72		-0.88	0.88	0.96	0.87	-0.87	0.83	0.75	0.53	0.55	-0.78	0.82	0.74
Short Term Debt	-0.82	-0.78	-0.86	-0.79	-0.88	-0.72	-0.83	-0.92	-0.86	-0.62	-0.73	-0.35	-0.64	-0.88		-0.75	-0.85	-0.72	0.76	-0.64	-0.62	-0.32	-0.5	0.57	-0.64	-0.59
Intangible Assets	0.9	0.89	0.91	0.83	0.75	0.9	0.87	0.84	0.88	0.66	0.86	0.46	0.7	0.88	-0.75		0.88	0.84	-0.98	0.83	0.8	0.5	0.54	-0.69	0.81	0.72
Common Stock	0.94	0.88	0.95	0.84	0.93	0.81	0.96	0.94	1.0	0.57	0.79	0.41	0.69	0.96	-0.85	0.88		0.8	-0.85	0.79	0.76	0.41	0.53	-0.67	0.78	0.71
Property Plant Equipment	0.93	0.91	0.91	0.79	0.71	0.98	0.87	0.84	0.83	0.92	0.75	0.44	0.94	0.87	-0.72	0.84	0.8		-0.9	0.96	0.91	0.34	0.82	-0.95	0.96	0.92
Other Current Liab	-0.9	-0.87	-0.9	-0.81	-0.76	-0.96	-0.85	-0.83	-0.87	-0.73	-0.83	-0.41	-0.8	-0.87	0.76	-0.98	-0.85	-0.9		-0.85	-0.82	-0.4	-0.67	0.74	-0.84	-0.78
Accounts Payable	0.94	0.92	0.89	0.74	0.66	0.93	0.9	0.79	0.8	0.9	0.71	0.52	0.89	0.83	-0.64	0.83	0.79	0.96	-0.85		0.96	0.38	0.76	-0.95	1.0	0.94
Non Current Assets Total	0.91	0.89	0.85	0.65	0.62	0.89	0.86	0.72	0.77	0.84	0.66	0.65	0.89	0.75	-0.62	0.8	0.76	0.91	-0.82	0.96		0.26	0.77	-0.88	0.96	0.9
Non Currrent Assets Other	0.46	0.6	0.54	0.77	0.14	0.33	0.48	0.53	0.39	0.29	0.77	0.46	0.0	0.53	-0.32	0.5	0.41	0.34	-0.4	0.38	0.26		-0.25	-0.43	0.32	0.08
Non Current Liabilities Total	0.66	0.55	0.57	0.33	0.6	0.81	0.58	0.51	0.58	0.79	0.29	0.15	0.96	0.55	-0.5	0.54	0.53	0.82	-0.67	0.76	0.77	-0.25		-0.73	0.8	0.91
Other Stockholder Equity	-0.86	-0.87	-0.83	-0.74	-0.53	-0.88	-0.81	-0.75	-0.69	-0.94	-0.69	-0.49	-0.86	-0.78	0.57	-0.69	-0.67	-0.95	0.74	-0.95	-0.88	-0.43	-0.73		-0.95	-0.88
Net Invested Capital	0.93	0.89	0.87	0.71	0.66	0.93	0.89	0.78	0.79	0.91	0.67	0.48	0.91	0.82	-0.64	0.81	0.78	0.96	-0.84	1.0	0.96	0.32	0.8	-0.95		0.96
Capital Stock	0.85	0.76	0.77	0.54	0.68	0.9	0.81	0.68	0.73	0.89	0.48	0.28	0.95	0.74	-0.59	0.72	0.71	0.92	-0.78	0.94	0.9	0.08	0.91	-0.88	0.96

Click cells to compare fundamentals

Shenzhen Bioeasy Account Relationship Matchups

Shenzhen Bioeasy fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	619.7M	652.9M	1.2B	1.3B	1.4B	869.7M
Total Current Liabilities	68.1M	78.1M	156.6M	199.8M	136.9M	111.1M
Total Stockholder Equity	528.4M	549.1M	944.8M	964.9M	849.0M	655.8M
Retained Earnings	163.4M	183.8M	402.3M	331.9M	138.4M	209.0M
Cash	420.8M	374.2M	339.2M	247.5M	481.7M	337.2M
Other Assets	11.7M	10.0M	28.9M	41.6M	47.9M	50.3M
Cash And Short Term Investments	183.1M	440.8M	374.2M	679.4M	781.4M	390.9M
Net Receivables	74.2M	62.3M	97.2M	83.9M	76.1M	73.0M
Liabilities And Stockholders Equity	296.8M	619.7M	652.9M	1.2B	1.3B	1.4B
Inventory	31.3M	61.6M	93.9M	100.6M	31.5M	55.9M
Other Current Assets	5.3M	4.9M	3.0M	213.3M	12.0M	11.4M
Total Liab	91.3M	103.8M	207.8M	317.8M	507.6M	533.0M
Total Current Assets	569.7M	526.1M	897.6M	674.4M	737.7M	600.8M
Intangible Assets	1.4M	44.1M	42.6M	42.4M	41.4M	27.2M
Property Plant Equipment	15.7M	29.4M	44.9M	143.4M	165.0M	173.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Shenzhen Stock

Balance Sheet is a snapshot of the financial position of Shenzhen Bioeasy Bio at a specified time, usually calculated after every quarter, six months, or one year. Shenzhen Bioeasy Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shenzhen Bioeasy and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shenzhen currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shenzhen Cost Of Revenue vs Net Income From Continuing Ops Analysis

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income From Continuing Ops

Shenzhen Bioeasy fundamental ratios Correlations

Shenzhen Bioeasy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shenzhen Bioeasy fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Shenzhen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Shares Outstanding
Net Invested Capital	+ 1.0	Accounts Payable
Total Stockholder Equity	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Net Receivables
Total Stockholder Equity	+ 0.98	Total Current Liabilities

Other Current Liab	- 0.98	Intangible Assets
Other Current Liab	- 0.96	Other Assets
Net Invested Capital	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Accounts Payable
Other Stockholder Equity	- 0.95	Property Plant Equipment
Other Stockholder Equity	- 0.94	Capital Surpluse